Stem Cell Regeneration Center Announces New Treatment Protocol for Diabetes Type I and II
Stem cell regeneration center of Thailand, a leading provider for Regenerative,Anti-Aging, & Functional Medicine announces a new permanent and non-surgical solution for the treatment of Diabetes Mellitus Type I and Type II.
The Diabetes Federation has estimated the diabetic population to mushroom to nearly half a billion patients by 2025. In China alone, there are over 90 million sufferers of Diabetes mellitus today.
“Unfortunately peoples sedentary lifestyles and poor dietary habits rich in refined and processed carbohydrates are trends we don’t see going away anytime soon.” said Mrs Lala Sudhatip, Vice President of Stem Cell Regeneration Center of Thailand. “Our goal is very simple, the treatment objectives for this new protocol to treat diabetes is to completely abolish or greatly reduce insulin dependency by more than 50% in 6 months after initial treatment.”
Major known contributors of diabetes Type I and Type II include hypoglycemic events such as acute low blood sugar and hyperglycemia or high blood sugar. Recent clinical studies have suggested an alarming fact that some diabetes prescription medications can contribute to heart heart disease and even heart failure. Men, women and even high risk children should get tested early. Those who that are diagnosed with onset diabetes should seek treatment immediately to reduce any hypoglycemic or hyperglycemia events that will without a doubt trigger other dangerous degenerative conditions.
The Treatment of Diabetes Mellitus type I and II in Thailand requires an estimated at 12-15 days in Bangkok.
About the Company
Stem Cell regeneration center of Thailand provides affordable cell treatments for a wide variety of medical diseases and ailments such as Kidney Disease, Diabetes type I and II, Liver Disease,Arthritis and Sports Injuries in Thailand. For More information about the new non-surgical solution to permanently please contact the center.
Cell Regeneration Center of Thailand
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.